Leidos Holdings, Inc. (NYSE:LDOS) Shares Sold by Cornercap Investment Counsel Inc.

Cornercap Investment Counsel Inc. lessened its holdings in Leidos Holdings, Inc. (NYSE:LDOS) by 44.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 12,210 shares of the aerospace company’s stock after selling 9,954 shares during the quarter. Leidos comprises approximately 0.6% of Cornercap Investment Counsel Inc.’s investment portfolio, making the stock its 13th largest holding. Cornercap Investment Counsel Inc.’s holdings in Leidos were worth $1,990,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Millennium Management LLC lifted its holdings in Leidos by 156.5% in the 2nd quarter. Millennium Management LLC now owns 1,133,508 shares of the aerospace company’s stock valued at $165,356,000 after purchasing an additional 691,575 shares in the last quarter. Wedge Capital Management L L P NC lifted its holdings in Leidos by 1,184.3% in the 2nd quarter. Wedge Capital Management L L P NC now owns 501,868 shares of the aerospace company’s stock valued at $73,213,000 after purchasing an additional 462,792 shares in the last quarter. International Assets Investment Management LLC increased its stake in shares of Leidos by 24,194.3% in the 3rd quarter. International Assets Investment Management LLC now owns 377,047 shares of the aerospace company’s stock worth $61,459,000 after acquiring an additional 375,495 shares during the last quarter. AQR Capital Management LLC increased its stake in shares of Leidos by 76.9% in the 2nd quarter. AQR Capital Management LLC now owns 698,807 shares of the aerospace company’s stock worth $101,942,000 after acquiring an additional 303,775 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD increased its stake in shares of Leidos by 138.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 517,498 shares of the aerospace company’s stock worth $67,840,000 after acquiring an additional 300,486 shares during the last quarter. Institutional investors and hedge funds own 76.12% of the company’s stock.

Wall Street Analysts Forecast Growth

LDOS has been the subject of a number of recent analyst reports. Wells Fargo & Company raised their price objective on Leidos from $183.00 to $230.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 30th. The Goldman Sachs Group lifted their price objective on Leidos from $205.00 to $228.00 and gave the company a “buy” rating in a research note on Wednesday, October 30th. TD Cowen boosted their target price on Leidos from $175.00 to $200.00 and gave the stock a “buy” rating in a research note on Wednesday, October 30th. Royal Bank of Canada lifted their price target on Leidos from $145.00 to $180.00 and gave the stock a “sector perform” rating in a research report on Wednesday, October 30th. Finally, Barclays lifted their price target on Leidos from $165.00 to $210.00 and gave the stock an “overweight” rating in a research report on Monday, November 4th. Two analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Leidos currently has an average rating of “Moderate Buy” and a consensus price target of $191.23.

Insider Buying and Selling at Leidos

In other Leidos news, Director Robert C. Kovarik, Jr. sold 1,047 shares of the company’s stock in a transaction that occurred on Thursday, October 31st. The stock was sold at an average price of $184.94, for a total value of $193,632.18. Following the completion of the transaction, the director now owns 6,408 shares of the company’s stock, valued at $1,185,095.52. This represents a 14.04 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Surya N. Mohapatra sold 2,748 shares of the company’s stock in a transaction that occurred on Thursday, November 7th. The shares were sold at an average price of $194.97, for a total value of $535,777.56. Following the completion of the transaction, the director now directly owns 20,001 shares of the company’s stock, valued at approximately $3,899,594.97. This trade represents a 12.08 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.96% of the company’s stock.

Leidos Trading Down 13.6 %

NYSE:LDOS opened at $167.96 on Friday. The company has a quick ratio of 1.15, a current ratio of 1.23 and a debt-to-equity ratio of 0.87. The business’s 50 day moving average is $169.15 and its two-hundred day moving average is $155.16. Leidos Holdings, Inc. has a 52 week low of $104.30 and a 52 week high of $202.90. The company has a market cap of $22.41 billion, a PE ratio of 19.13, a P/E/G ratio of 1.30 and a beta of 0.68.

Leidos (NYSE:LDOS) last posted its earnings results on Tuesday, October 29th. The aerospace company reported $2.93 EPS for the quarter, beating the consensus estimate of $1.96 by $0.97. Leidos had a return on equity of 30.31% and a net margin of 7.37%. The firm had revenue of $4.19 billion for the quarter, compared to analysts’ expectations of $4.06 billion. During the same period last year, the firm earned $2.03 EPS. The firm’s revenue was up 6.9% compared to the same quarter last year. On average, analysts predict that Leidos Holdings, Inc. will post 10.07 EPS for the current year.

Leidos Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 31st. Shareholders of record on Monday, December 16th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Friday, December 13th. This represents a $1.60 dividend on an annualized basis and a yield of 0.95%. This is an increase from Leidos’s previous quarterly dividend of $0.38. Leidos’s payout ratio is 17.31%.

Leidos Company Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.